Fang-Yi Su
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 7
- Advancements in Transdermal Drug Delivery 2
-
- Lipid Membrane Structure and Behavior 3
- RNA Interference and Gene Delivery 2
- Co-authors
- Hsing‐Wen Sung (8 shared papers)Er‐Yuan Chuang (8 shared papers)Kun‐Ju Lin (7 shared papers)Tzu‐Chen Yen (6 shared papers)Kiran Sonaje (3 shared papers)Michael T. Tseng (2 shared papers)Shiaw‐Pyng Wey (4 shared papers)Chiung-Tong Chen (5 shared papers)
- Journals
- Biomaterials (6 papers)Journal of Controlled Release (2 papers)Molecular Pharmaceutics (1 paper)Nanomedicine Nanotechnology Biology and Medicine (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Fang-Yi Su
12 papers receiving 878 citations
Peers
Comparison fields: 5 of 96
- Pharmaceutical Science 475
- Biomaterials 210
- Molecular Medicine 45
- Molecular Biology 319
- Food Science 78
Countries citing papers authored by Fang-Yi Su
This map shows the geographic impact of Fang-Yi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang-Yi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang-Yi Su more than expected).
Fields of papers citing papers by Fang-Yi Su
This network shows the impact of papers produced by Fang-Yi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang-Yi Su. The network helps show where Fang-Yi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fang-Yi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 193 | |
| 2 | 2012 | 159 | |
| 3 | 2011 | 116 | |
| 4 | 2013 | 86 | |
| 5 | 2012 | 75 | |
| 6 | 2012 | 59 | |
| 7 | 2013 | 50 | |
| 8 | 2018 | 45 | |
| 9 | 2013 | 44 | |
| 10 | 2016 | 24 | |
| 11 | 2019 | 20 | |
| 12 | 2014 | 12 |
About Fang-Yi Su
Fang-Yi Su is a scholar working on Pharmaceutical Science, Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials and Organic Chemistry, having authored 12 papers that have together received 883 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (7 papers), Lipid Membrane Structure and Behavior (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Pancreatic function and diabetes (1 paper) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Pharmaceutical Science (475 citations), Biomaterials (210 citations), Molecular Medicine (45 citations), Molecular Biology (319 citations) and Food Science (78 citations). Fang-Yi Su has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Hsing‐Wen Sung, Er‐Yuan Chuang, Kun‐Ju Lin, Tzu‐Chen Yen, Kiran Sonaje, Michael T. Tseng, Shiaw‐Pyng Wey, Chiung-Tong Chen, Yi‐Cheng Ho and Barnali Maiti. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Molecular Pharmaceutics, Nanomedicine Nanotechnology Biology and Medicine and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.